TI
AVXL icon

Trexquant Investment’s Anavex Life Sciences AVXL Stock Holding History

Trexquant Investment’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-71,107
Closed -$610K – 1511
2025
Q1 		$610K Sell
71,107
-367
-0.5% -$3.47K 0.01% 1233
2024
Q4 		$768K Buy
71,474
+15,109
+27% +$116K 0.01% 1180
2024
Q3 		$320K Buy
+56,365
New +$325K ﹤0.01% 1338
2024
Q2 		– Sell
-83,185
Closed -$423K – 1510
2024
Q1 		$423K Buy
83,185
+25,530
+44% +$144K 0.01% 1199
2023
Q4 		$537K Buy
+57,655
New +$397K 0.01% 1058
2023
Q2 		– Sell
-59,695
Closed -$512K – 1430
2023
Q1 		$512K Sell
59,695
-123,418
-67% -$1.23M 0.01% 988
2022
Q4 		$1.7M Buy
183,113
+166,363
+993% +$1.78M 0.05% 468
2022
Q3 		$173K Sell
16,750
-13,271
-44% -$140K 0.01% 1222
2022
Q2 		$301K Buy
+30,021
New +$284K 0.01% 1114
2022
Q1 		– Sell
-13,601
Closed -$236K – 1345
2021
Q4 		$236K Sell
13,601
-1,654
-11% -$31.4K 0.01% 1050
2021
Q3 		$274K Buy
+15,255
New +$304K 0.02% 782

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Trexquant Investment's AVXL Position: Q2 2025 in Review

Trexquant Investment sold out of Anavex Life Sciences (AVXL) in Q2 2025, closing a stake of 71,107 shares — an estimated $610K sold.

Trexquant Investment first reported a position in AVXL in Q3 2021 and held it in 11 quarters. The position peaked at $1.7M in Q4 2022. 178 funds tracked by Wall St. Rank hold AVXL as of Q2 2025.

  • Trexquant Investment reported no remaining Anavex Life Sciences position as of Q2 2025 after selling out during the quarter.
  • Trexquant Investment sold 71,107 Anavex Life Sciences shares in Q2 2025, an estimated $610K.
  • Trexquant Investment first reported a position in Anavex Life Sciences in Q3 2021 and held it in 11 quarters.
  • Trexquant Investment's Anavex Life Sciences position peaked at $1.7M in Q4 2022.
  • 178 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2025.

Based on Trexquant Investment's 13F filing for Q2 2025, filed 12 Aug 2025.